February 8, 2012 (New Orleans, Louisiana) — New data from 2 large phase 3 trials that compared the novel factor Xa inhibitor apixaban (Eliquis, Pfizer/Bristol-Myers Squibb) with warfarin and aspirin, ...

Apixaban may be safer and more effective than rivaroxaban for treating nonvalvular atrial fibrillation (AF), a new observational study suggests. The study, one of the largest to compare the two drugs ...

Please provide your email address to receive an email when new articles are posted on . Apixaban tied to less stroke and bleeding in patients with/without dementia vs. dabigatran, rivaroxaban or ...

Please provide your email address to receive an email when new articles are posted on . Apixaban did not reduce recurrent stroke risk in patients with atrial cardiopathy without AF. The ARCADIA trial ...

Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot ...

For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban. Data remain inconclusive regarding ...

MUNICH, Germany—Among patients with an embolic stroke of undetermined source (ESUS) and signs of atrial cardiopathy, a direct oral anticoagulant (DOAC) is no better than aspirin for preventing ...

London, United Kingdom – 1 September 2024: Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to ...

An individually tailored multidimensional risk-based treatment strategy was not associated with improvements in clinical ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Older adults ...

Patients with atrial fibrillation (AF) who’ve recently experienced an acute coronary syndrome or undergone PCI are best served by an antithrombotic strategy that includes a P2Y12 inhibitor and a ...

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of ...